Last updated on March 2020

A Study of NKTR-214 in Combination With Nivolumab Compared With the Investigator's Choice of a Tyrosine Kinase Inhibitor (TKI) Therapy (Either Sunitinib or Cabozantinib Monotherapy) for Advanced Metastatic Renal Cell Carcinoma (RCC)


Brief description of study

The main purpose of this study is to compare the overall response rate (ORR) and overall survival (OS) of bempegaldesleukin (NKTR-214) combined with nivolumab to that of tyrosine kinase inhibitor (TKI) monotherapy (sunitinib or cabozantinib) in IMDC intermediate- or poor-risk patients and IMDC all-risk patients with previously untreated advanced renal cell carcinoma (RCC).

Clinical Study Identifier: NCT03729245

Find a site near you

Start Over

Investigator Site - Goodyear

Goodyear, AZ United States
  Connect »

Investigator Site - Whittier

Whittier, CA United States
  Connect »

Investigator Site - Kettering

Kettering, OH United States
  Connect »

Investigator Site - Portland

Portland, OR United States
  Connect »

Investigator Site - Houston

Houston, TX United States
  Connect »

Investigator Site - Fairfax

Fairfax, VA United States
  Connect »

Investigator Site - Leesburg

Leesburg, VA United States
  Connect »

Investigator Site - Saint Petersburg

Saint Petersburg, Russian Federation
  Connect »

Investigator Site - Little Rock

Little Rock, AR United States
  Connect »

Investigator Site - East Setauket

East Setauket, NY United States
  Connect »

Investigator Site - Allentown

Allentown, PA United States
  Connect »

Investigator Site - Chattanooga

Chattanooga, TN United States
  Connect »

Investigator Site - Anchorage

Anchorage, AK United States
  Connect »

Investigator Site - Barnaul

Barnaul, Russian Federation
  Connect »

Investigator Site - Chelyabinsk

Chelyabinsk, Russian Federation
  Connect »

Investigator Site - Kursk

Kursk, Russian Federation
  Connect »

Investigator Site - Moscow

Moscow, Russian Federation
  Connect »

Investigator Site - Omsk

Omsk, Russian Federation
  Connect »

Investigator Site - Pushkin

Pushkin, Russian Federation
  Connect »

Investigator Site - Volzhskiy

Volzhskiy, Russian Federation
  Connect »

Investigator Site - Yaroslavl

Yaroslavl, Russian Federation
  Connect »

Investigator Site - Atlanta

Atlanta, GA United States
  Connect »

Investigator Site - Baltimore

Baltimore, MD United States
  Connect »

Investigator Site - Henderson

Henderson, NV United States
  Connect »

Investigator Site - New York

New York, NY United States
  Connect »

Investigator Site - Bethlehem

Bethlehem, PA United States
  Connect »

Investigator Site - Philadelphia

Philadelphia, PA United States
  Connect »

Investigator Site - Pittsburgh

Pittsburgh, PA United States
  Connect »

Investigator Site - Salt Lake City

Salt Lake City, UT United States
  Connect »

Investigator Site - Obninsk

Obninsk, Russian Federation
  Connect »

Investigator Site - Rostov-on-Don

Rostov-on-Don, Russian Federation
  Connect »

Investigator Site - Los Angeles

Los Angeles, CA United States
  Connect »

Investigator Site - New Orleans

New Orleans, LA United States
  Connect »